<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d388">
    <sentence id="DDI-DrugBank.d388.s0" text="Catecholamine-depleting drugs, such as reserpine, may have an additive effect when given with beta-blocking agents.">
        <entity charOffset="0-28" id="DDI-DrugBank.d388.s0.e0" text="Catecholamine-depleting drugs" type="group"/>
        <entity charOffset="39-47" id="DDI-DrugBank.d388.s0.e1" text="reserpine" type="drug"/>
        <entity charOffset="94-113" id="DDI-DrugBank.d388.s0.e2" text="beta-blocking agents" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s0.e0" e2="DDI-DrugBank.d388.s0.e1" id="DDI-DrugBank.d388.s0.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d388.s0.e0" e2="DDI-DrugBank.d388.s0.e2" id="DDI-DrugBank.d388.s0.p1" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d388.s0.e1" e2="DDI-DrugBank.d388.s0.e2" id="DDI-DrugBank.d388.s0.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d388.s1" text="Patients treated with acebutolol plus catecholamine depletors should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure without compensatory tachycardia.">
        <entity charOffset="22-31" id="DDI-DrugBank.d388.s1.e0" text="acebutolol" type="drug"/>
        <entity charOffset="38-60" id="DDI-DrugBank.d388.s1.e1" text="catecholamine depletors" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d388.s1.e0" e2="DDI-DrugBank.d388.s1.e1" id="DDI-DrugBank.d388.s1.p0" type="advise"/>
    <negationtags>Patients treated with acebutolol plus catecholamine depletors should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure &lt;scope&gt; &lt;cue&gt; without &lt;/cue&gt; compensatory tachycardia. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d388.s2" text="Exaggerated hypertensive responses have been reported from the combined use of beta-adrenergic antagonists and alpha-adrenergic stimulants, including those contained in proprietary cold remedies and vasoconstrictive nasal drops.">
        <entity charOffset="79-105" id="DDI-DrugBank.d388.s2.e0" text="beta-adrenergic antagonists" type="group"/>
        <entity charOffset="111-137" id="DDI-DrugBank.d388.s2.e1" text="alpha-adrenergic stimulants" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d388.s2.e0" e2="DDI-DrugBank.d388.s2.e1" id="DDI-DrugBank.d388.s2.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d388.s3" text="Patients receiving beta-blockers should be warned of this potential hazard.">
        <entity charOffset="19-31" id="DDI-DrugBank.d388.s3.e0" text="beta-blockers" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d388.s4" text="Blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by nonsteroidal anti-inflammatory drugs has been reported.">
        <entity charOffset="43-75" id="DDI-DrugBank.d388.s4.e0" text="beta-adrenoceptor blocking agents" type="group"/>
        <entity charOffset="80-115" id="DDI-DrugBank.d388.s4.e1" text="nonsteroidal anti-inflammatory drugs" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d388.s4.e0" e2="DDI-DrugBank.d388.s4.e1" id="DDI-DrugBank.d388.s4.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d388.s5" text="No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.">
        <entity charOffset="33-39" id="DDI-DrugBank.d388.s5.e0" text="digoxin" type="drug"/>
        <entity charOffset="42-60" id="DDI-DrugBank.d388.s5.e1" text="hydrochlorothiazide" type="drug"/>
        <entity charOffset="63-73" id="DDI-DrugBank.d388.s5.e2" text="hydralazine" type="drug"/>
        <entity charOffset="76-89" id="DDI-DrugBank.d388.s5.e3" text="sulfinpyrazone" type="drug"/>
        <entity charOffset="97-110" id="DDI-DrugBank.d388.s5.e4" text="contraceptives" type="group"/>
        <entity charOffset="113-123" id="DDI-DrugBank.d388.s5.e5" text="tolbutamide" type="drug"/>
        <entity charOffset="129-136" id="DDI-DrugBank.d388.s5.e6" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e0" e2="DDI-DrugBank.d388.s5.e1" id="DDI-DrugBank.d388.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e0" e2="DDI-DrugBank.d388.s5.e2" id="DDI-DrugBank.d388.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e0" e2="DDI-DrugBank.d388.s5.e3" id="DDI-DrugBank.d388.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e0" e2="DDI-DrugBank.d388.s5.e4" id="DDI-DrugBank.d388.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e0" e2="DDI-DrugBank.d388.s5.e5" id="DDI-DrugBank.d388.s5.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e0" e2="DDI-DrugBank.d388.s5.e6" id="DDI-DrugBank.d388.s5.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e1" e2="DDI-DrugBank.d388.s5.e2" id="DDI-DrugBank.d388.s5.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e1" e2="DDI-DrugBank.d388.s5.e3" id="DDI-DrugBank.d388.s5.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e1" e2="DDI-DrugBank.d388.s5.e4" id="DDI-DrugBank.d388.s5.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e1" e2="DDI-DrugBank.d388.s5.e5" id="DDI-DrugBank.d388.s5.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e1" e2="DDI-DrugBank.d388.s5.e6" id="DDI-DrugBank.d388.s5.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e2" e2="DDI-DrugBank.d388.s5.e3" id="DDI-DrugBank.d388.s5.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e2" e2="DDI-DrugBank.d388.s5.e4" id="DDI-DrugBank.d388.s5.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e2" e2="DDI-DrugBank.d388.s5.e5" id="DDI-DrugBank.d388.s5.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e2" e2="DDI-DrugBank.d388.s5.e6" id="DDI-DrugBank.d388.s5.p14"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e3" e2="DDI-DrugBank.d388.s5.e4" id="DDI-DrugBank.d388.s5.p15"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e3" e2="DDI-DrugBank.d388.s5.e5" id="DDI-DrugBank.d388.s5.p16"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e3" e2="DDI-DrugBank.d388.s5.e6" id="DDI-DrugBank.d388.s5.p17"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e4" e2="DDI-DrugBank.d388.s5.e5" id="DDI-DrugBank.d388.s5.p18"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e4" e2="DDI-DrugBank.d388.s5.e6" id="DDI-DrugBank.d388.s5.p19"/>
        <pair ddi="false" e1="DDI-DrugBank.d388.s5.e5" e2="DDI-DrugBank.d388.s5.e6" id="DDI-DrugBank.d388.s5.p20"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No significant &lt;/cue&gt; interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed. &lt;/scope&gt;</negationtags></sentence>
</document>